All In MedTech

Device Trial Radar · NCT02922088

EU Multicenter Registry to Assess Outcomes in CABG Patients: Treatment of Vascular Conduits With DuraGraft [VASC]

European (EU) Multi-Center Registry to Assess Outcomes in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery: Treatment of Vascular Conduits With DuraGraft®, a Novel Endothelial Damage Inhibitor [VASC]

Last checked: Nov 21, 2026Latest source record: Mar 18, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

2,964

Actual

Start

Dec 9, 2016

Primary completion

Aug 2024

Study completion Dec 2024

Sponsor

Lead sponsor
Somahlution LLCNot on our public-company list
Sponsor type
Industry
First posted
Oct 3, 2016

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The DuraGraft® Registry is a European registry of patients who have undergone CABG and whose vascular grafts have been treated with DuraGraft. All participating sites will be from countries in Europe. The DuraGraft Registry will collect pre-CABG, intraoperative and post-operative data, major post-CABG cardiovascular adverse events, health economic outcomes and patient reported quality of life over a period of 5 years.

Conditions

  • Cardiovascular Diseases
  • Coronary Artery Disease

Interventions

  • DuraGraftDevice

    DuraGraft is a one-time intraoperative vascular graft treatment designed to prevent graft disease and failure and reduce the clinical complications associated with graft failure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Major Adverse Cardiac Events (MACE)Time frame: Annually up to 5 years post-CABG Surgery

Locations

36 sites in 8 countries. Site status is shown where the registry gives one.

  • Medical University of Vienna

    Vienna, Austria

35 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.